Hepatic encephalopathy: how to test and treat

Area of Science:

• Hepatology
• Neurology
• Gastroenterology

Background:

• Hepatic encephalopathy (HE) significantly impairs cognition and morbidity in cirrhosis patients.
• HE is a reversible syndrome, but its pathophysiology, including ammonia's role, is not fully understood.
• Effective management strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To review studies on diagnostic tools for hepatic encephalopathy.
• To highlight emerging treatments for hepatic encephalopathy.
• To discuss advancements in managing cognitive dysfunction in cirrhosis.

Main Methods:

• Review of studies on hepatic encephalopathy diagnosis and treatment.
• Evaluation of a smartphone-based Stroop app for covert HE detection.
• Analysis of therapeutic interventions including lactulose, probiotics, and other agents.

Main Results:

• A smartphone Stroop app aids in detecting covert hepatic encephalopathy (CHE).
• Lactulose and probiotics show efficacy in preventing overt HE (OHE) episodes.
• L-ornithine-L-aspartate and potassium-iron-phosphate-citrate have been studied for CHE treatment; Rifaximin is effective for OHE remission but less cost-effective than lactulose for CHE.

Conclusions:

• Clinical management strategies for cirrhosis patients with HE are continually refined.
• These refinements contribute to better patient outcomes.
• Ongoing research into HE diagnostics and therapeutics is vital.